Figure 3From: Changes in cortical cytoskeletal and extracellular matrix gene expression in prostate cancer are related to oncogenic ERG deregulation Immunohistochemical analysis of protein 4.1B expression in prostate cancer and benign prostatic glands. A and B: Heterogeneous expression of protein 4.1B in benign prostatic glands. Note stronger expression levels in basal cells (arrows) than in secretory epithelial cells. C-D: Comparison of 4.1B expression levels in tumor glands (TU) and corresponding benign prostatic glands (N): C and D: equivalent and slightly decreased, respectively, 4.1B expression in cancer cells compared to secretory cells of normal glands. Original magnifications: A, D, x200; B, x400; C, x100. E: negative control without primary antibody.Back to article page